Model
Edge
Nektar Therapeutics
NKTR
Filing Type
S-8
Filing Date
8/7/2025
Updated
8/7/25, 5:46 PM
Filing
S-8
Earnings Release
Exhibits
S-8
Registration Statement for Securities to be Offered to Employees
EX-4.8
NEKTAR THERAPEUTICS AMENDED AND RESTATED 2017 PERFORMANCE INCENTIVE PLAN, AS AMENDED
EX-5.1
OPINION OF GOODWIN PROCTER LLP WITH RESPECT TO THE VALIDITY OF THE SECURITIES
EX-23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
EX-FILING FEES
FILING FEE TABLE
GRAPHIC
Graphic